Issue Archive
|
About Us
|
Contact Us
|
Subscribe
|
Editorial Board
|
Author Guidelines
|
About Haymarket Media
Home
News
Web Exclusives
Daily Oncology News
New Drug Products
ASH 2011
ASCO 2011
ONS Annual Congress 2011
ASH 2010
CE
CE Articles
mycme.com
Departments
Advisor Forum
Ask a Pharmacist
Case of the Month
Case Study
Communication Challenges
From CancerCare
Issues in Cancer Survivorship
Radiation and Your Patient
Reflections
Stat Consult
The Patient's Voice
The Total Patient
Issue Archive
Topics
Chemotherapy
Communication
End-of-Life Issues
Pain Management
Palliative Care
Radiology
Side-Effect Management
Survivorship
Women's Health
Cancer Types
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Chemotherapy Regimens
Clinical Trials
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
For Your Patient
Advocacy
CancerCare Fact Sheets
Cancer Support Groups
Financial Assistance
Finding Clinical Trials
Palliative Care and Hospice
Patient Information
The Total Nurse
General Medicine in Oncology
Slideshows
Supplements
Jobs
Tools & Links
RSS
|
Login
|
Register
ONA
>
Focus on
> Kidney Cancer
Kidney Cancer News & Features
How kidney cancer therapies could improve quality of life
Tom Moberly January 26, 2010
Kidney cancer drugs in development could improve patients' quality of life and allow more effective treatment, according to Professor Robert Hawkins of Manchester University.
Palliative care in endstage renal failure
Joanna Peasegood; Aine Burns January 22, 2010
For some patients with end stage renal failure, management with options other than dialysis is preferred, and this article reviews the symtoms these patients experience.
Wilms' tumour: Assessing and managing nephroblastoma
Suneeta Kochhar; Catherine R. Mungalsingh; Salah Mansy January 22, 2010
Reviews the clinical features and diagnosis of Wilm's tumor, as well as management and follow up
Kidney Cancer News from Renal & Urology News
Kidney Cancer
Kidney Cancer Tumor Size, Preoperative eGFR Linked
Jody A. Charnow
January 30, 2012
Tumor diameter and decreased preoperative estimated glomerular filtration rate (eGFR) are independently correlated in patients undergoing surgery for renal cell carcinoma (RCC), researchers concluded.
Kidney Cancer
Adrenalectomy Rates Remain High in Radical Nephrectomy
Jody A. Charnow
January 30, 2012
During a recent 10-year period, the rate of ipsilateral adrenalectomy at the time of radical nephrectomy decreased slightly, a study found.
Kidney Cancer
Radiofrequency Ablation, Partial Nephrectomy for RCC Offer Similar Long-Term Outcomes
Jody A. Charnow
January 11, 2012
In appropriately selected patients, radiofrequency ablation (RFA) is an effective minimally invasive treatment for cT1a renal cell carcinoma (RCC) that offers long-term oncologic outcomes comparable to nephron-sparing surgery, data show.
Kidney Cancer
Ultrasound Not Inferior for Sizing Renal Masses
Jody A. Charnow
January 06, 2012
Ultrasound imaging works as well as computed tomography (CT) and magnetic resonance imaging (MRI) for evaluating renal mass size, a new study suggests.
Kidney Cancer
Increased Lead Exposure May Raise Kidney Cancer Risk
Jody A. Charnow
January 02, 2012
Higher blood lead levels are associated with an elevated risk of renal cell carcinoma (RCC), according to a study.
more »
Kidney Cancer Clinical Trials
Clinical Trial: VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer
Clinical Trial: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Clinical Trial: MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer
Clinical Trial: Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer (CMM)
Clinical Trials: Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer
more »
Free CE from mycme.com
Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer
2.00
/
AMA PRA Category 1 Credit(s)
TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
FEBRUARY 3 - 4
•
2012 Highlights of ASH in North America
New York, New York
•
2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
•
2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
•
37th Annual ONS Congress
New Orleans, Louisiana
Click here to view the full calendar
Subscribe to the RSS for this page [
view all our RSS feeds here
]
Web Exclusives
Psychosocial approach useful in managing cancer pain
Delicia Honen Yard
February 03, 2012
Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
Experimental agent slows progression of colorectal cancer
Delicia Honen Yard
February 02, 2012
The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
In HER2 breast cancer, lapatinib works better with trastuzumab than without
Delicia Honen Yard
February 01, 2012
Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
more »